High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1

por Schehr, Jennifer L., Schultz, Zachery D., Warrick, Jay W., Guckenberger, David J., Pezzi, Hannah M., Sperger, Jamie M., Heninger, Erika, Saeed, Anwaar, Leal, Ticiana, Mattox, Kara, Traynor, Anne M., Campbell, Toby C., Berry, Scott M., Beebe, David J., Lang, Joshua M.
Publicado 2016

Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cel...

por Schehr, Jennifer L., Sethakorn, Nan, Schultz, Zachery D., Hernandez, Camila I., Bade, Rory M., Eyzaguirre, Diego, Singh, Anupama, Niles, David J., Henderson, Leslie, Warrick, Jay W., Berry, Scott M., Sundling, Kaitlin E., Beebe, David J., Leal, Ticiana A., Lang, Joshua M.
Publicado 2022

A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer

por Zhao, Shuang G., Sperger, Jamie M., Schehr, Jennifer L., McKay, Rana R., Emamekhoo, Hamid, Singh, Anupama, Schultz, Zachery D., Bade, Rory M., Stahlfeld, Charlotte N., Gilsdorf, Cole S., Hernandez, Camila I., Wolfe, Serena K., Mayberry, Richel D., Krause, Hannah M., Bootsma, Matt, Helzer, Kyle T., Rydzewski, Nicholas, Bakhtiar, Hamza, Shi, Yue, Blitzer, Grace, Kyriakopoulos, Christos E., Kosoff, David, Wei, Xiao X., Floberg, John, Sethakorn, Nan, Sharifi, Marina, Harari, Paul M., Huang, Wei, Beltran, Himisha, Choueiri, Toni K., Scher, Howard I., Rathkopf, Dana E., Halabi, Susan, Armstrong, Andrew J., Beebe, David J., Yu, Menggang, Sundling, Kaitlin E., Taplin, Mary-Ellen, Lang, Joshua M.
Publicado 2022